Psychiatry and the scientific fallacy

Acta Psychiatrica Scandinavica

Volumn 124, Issue 1, 2011, Pages 70-72

  Saraga, Michael ^a   Stiefel, Friedrich ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOZAPINE; INOSITOL; LAMOTRIGINE; NEUROLEPTIC AGENT; PERPHENAZINE; RISPERIDONE;

ARTICLE; BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL DECISION MAKING; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG INDUSTRY; DRUG TOLERABILITY; EMPIRICISM; EVIDENCE BASED MEDICINE; HONESTY; HUMAN; LATENT PERIOD; LOGIC; MENTAL DISEASE; NEUROSCIENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRY; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIZOPHRENIA; SCIENTIFIC FALLACY; TREATMENT RESPONSE;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVIDENCE-BASED MEDICINE; HUMANS; MENTAL DISORDERS; PSYCHIATRY; PUBLICATION BIAS;

EID: 79958772181     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01708.x     Document Type: Article

References (15)

1. Feynman RP. "Surely you're joking, Mr. Feynman!": adventures of a curious character. 1997.
2. Landmark Council Session Spotlights "Real World" Trials. 2006 Available from: [updated 2006; cited 2010 September 16].
3. Lieberman JA, Strop TS, Mcevoy JP et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-1223.
4. Rush AJ, Trivedi MH, Wisniewski SR et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917.
5. Perlis RH, Ostacher MJ, Patel JK et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006;163:217-224.
6. Freedman R. The choice of antipsychotic drugs for schizophrenia. N Engl J Med 2005;353:1286-1288.
7. Rubinow DR. Treatment strategies after SSRI failure--good news and bad news. N Engl J Med 2006;354:1305-1307.
8. Valenstein M. Keeping our eyes on STAR*D. Am J Psychiatry 2006;163:1484-1486.
9. Odds of Beating Depression Diminish as Additional Treatment Strategies are Needed. 2006 [updated 2006; cited 2010 February 17]; Available from:.
10. Depaulo JR Jr. Bipolar disorder treatment: an evidence-based reality check. Am J Psychiatry 2006;163:175-176.
11. Shern DL, Moran H. STAR*D: helping to close the gap between science and practice. Psychiatr Serv 2009;60:1458-1459.
12. Rush AJ. STAR*D: what have we learned? Am J Psychiatry 2007;164:201-204.
13. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008;358:252-260.
14. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. The conceptual development of DSM-V. Am J Psychiatry 2009;166:645-650.
15. Parikh SV. Antidepressants are not all created equal. Lancet 2009;373:700-701.